Marion Delcroix

Marion Delcroix, MD, PhD, is Professor of Medicine and of Respiratory Physiology at the Universities of Leuven and Kortrijk, Belgium. She is Head of the Pulmonary Hypertension (PH) Program, Chair of the Council for Rare Diseases of the University Hospitals of Leuven and Director of the KU Leuven Institute for rare Diseases. She has been involved in the routine care of over 2000 patients with PH and has participated in main pivotal trials for the treatment of pulmonary arterial hypertension (PAH). Marion Delcroix is a founding member and chair of the International CTEPH Association (ICA). She has over 200 publications, with research interests focusing on pulmonary circulation and gas exchange, cardiac imaging, and the role of inflammation in the pathogenesis of PAH and CTEPH. She has been associated editor of the European Respiratory Journal (ERJ) and deputy editor of the Journal of Heart and Lung Transplantation (JHLT). Lastly, she was involved as core member for PH in the European Reference Network (ERN)-lung, as Assembly Head for Pulmonary Vascular Diseases of the European Respiratory Society (ERS), as co-chair of PHAROS ERS Clinical Research Collaboration, and as scientific board member of the World Symposia on Pulmonary Hypertension Association (WSPH). She is a fellow of the ESC and of the ERS, and was co-chair of the ESC/ERS 2022 PH guidelines.